CIFPRETIA Trademark

Trademark Overview


On Tuesday, June 7, 2022, a trademark application was filed for CIFPRETIA with the United States Patent and Trademark Office. The USPTO has given the CIFPRETIA trademark a serial number of 97446970. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, November 5, 2024. This trademark is owned by Pfizer Inc.. The CIFPRETIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
cifpretia

General Information


Serial Number97446970
Word MarkCIFPRETIA
Filing DateTuesday, June 7, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, November 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, June 10, 2022NEW APPLICATION ENTERED
Thursday, June 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 14, 2023ASSIGNED TO EXAMINER
Thursday, March 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 13, 2023SOU EXTENSION 1 GRANTED
Tuesday, June 6, 2023ASSIGNED TO EXAMINER
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 13, 2023SOU EXTENSION 1 FILED
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 14, 2024SOU EXTENSION 2 FILED
Tuesday, May 14, 2024SOU EXTENSION 2 GRANTED
Wednesday, May 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 5, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, November 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 5, 2024SOU EXTENSION 3 FILED
Tuesday, November 5, 2024SOU EXTENSION 3 GRANTED
Tuesday, May 14, 2024SOU TEAS EXTENSION RECEIVED